Global Cell Line Development Market

Cell Line Development Market Size, Share, Growth Analysis, By Product (Equipment, Media & Reagents), By Source (Mammalian, Insect), By Type (Primary Cell Lines, Continuous Cell Lines), By Application (Tissue Engineering & Regenerative Medicine, Drug Discovery), By Region - Industry Forecast 2025-2032

Report ID: SQMIG35H2261 | Region: Global | Published Date: November, 2024
Pages: 203 | Tables: 120 | Figures: 71

Cell Line Development Market Competitive Landscape

Creating cell lines for specific applications will help companies maximize their business scope and also set them apart from the competition. Developing novel cell line development products and services will also help boost market growth over the coming years. Cell line development companies can take advantage of supportive government initiatives and funding to maximize their business scope in the long run.

Top Player’s Company Profiles

  • American Type Culture Collection (ATCC) (US) 
  • Corning, Inc. (US) 
  • European Collection of Cell Cultures (ECACC) (UK) 
  • GE Healthcare (US) 
  • Lonza Group AG (Switzerland) 
  • Sartorius AG (Germany) 
  • JSR Life Sciences (US) 
  • MERCK KGaA (Germany) 
  • Thermo Fisher Scientific, Inc. (US) 
  • Wuxi Apptec (China) 
  • Celltrion, Inc. (South Korea) 
  • Bio-Techne Corporation (US) 
  • Charles River Laboratories International, Inc. (US) 
  • Eppendorf AG (Germany) 
  • Fujifilm Diosynth Biotechnologies (Japan) 
  • Promega Corporation (US) 
  • Danaher Corporation (US) 
  • Thermo Fisher Scientific (US) 
  • Perkin-Elmer (US) 
  • Cell Culture Technologies (US) 
  • Takara Bio Inc. (Japan)

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Cell Line Development Market size was valued at USD 4.7 billion in 2022 and is poised to grow from USD 5.16 billion in 2023 to USD 10.94 billion by 2031, growing at a CAGR of 9.84% during the forecast period (2024-2031).

Creating cell lines for specific applications will help companies maximize their business scope and also set them apart from the competition. Developing novel cell line development products and services will also help boost market growth over the coming years. Cell line development companies can take advantage of supportive government initiatives and funding to maximize their business scope in the long run. 'American Type Culture Collection (ATCC) (US) ', 'Corning, Inc. (US) ', 'European Collection of Cell Cultures (ECACC) (UK) ', 'GE Healthcare (US) ', 'Lonza Group AG (Switzerland) ', 'Sartorius AG (Germany) ', 'JSR Life Sciences (US) ', 'MERCK KGaA (Germany) ', 'Thermo Fisher Scientific, Inc. (US) ', 'Wuxi Apptec (China) ', 'Celltrion, Inc. (South Korea) ', 'Bio-Techne Corporation (US) ', 'Charles River Laboratories International, Inc. (US) ', 'Eppendorf AG (Germany) ', 'Fujifilm Diosynth Biotechnologies (Japan) ', 'Promega Corporation (US) ', 'Danaher Corporation (US) ', 'Thermo Fisher Scientific (US) ', 'Perkin-Elmer (US) ', 'Cell Culture Technologies (US) ', 'Takara Bio Inc. (Japan)'

Healthcare researchers around the world are focusing on unlocking the full potential of cells and this has resulted in significant investments in cell research. Cell line development plays a crucial role in cell research thereby driving market growth potential as well.

3D Cell Culture: Cell line development companies can ride the wave of rising demand for 3D cell culture and organoid development to maximize their business potential in the future. Providing cell line development specifically aimed at advancing 3D cell culture and organoid development could be the key to maximizing business growth in the long run.

North America is estimated to lead the demand for cell line development in the world owing to high investments in medical R&D and the presence of a developed healthcare infrastructure. Presence of key biotechnology companies and supportive government initiatives to advanced medical research are also expected to create new opportunities for cell line development companies. Growing awareness regarding benefits of novel biologics and increased adoption of the same will also help this region’s dominance. The United States is projected to be the top market for cell line development companies in this region.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Feedback From Our Clients

Global Cell Line Development Market

Report ID: SQMIG35H2261

$5,300
BUY NOW GET FREE SAMPLE